13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000950123-24-011470
Total Value
$186.8M
Positions
29
Other Managers
1
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 150,833 | $11.0M | 5.89% |
| 2 | TARSUS PHARMACEUTICALS INC | TARS | 321,898 | $10.6M | 5.67% |
| 3 | MERUS N V | N5749R100 | 208,244 | $10.4M | 5.57% |
| 4 | CG ONCOLOGY INC | CGON | 263,266 | $9.9M | 5.32% |
| 5 | BLUEPRINT MEDICINES CORP | 09627Y109 | 106,080 | $9.8M | 5.25% |
| 6 | SAREPTA THERAPEUTICS INC | SRPT | 72,000 | $9.0M | 4.81% |
| 7 | XENON PHARMACEUTICALS INC | XENE | 211,791 | $8.3M | 4.46% |
| 8 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 240,892 | $8.0M | 4.30% |
| 9 | JASPER THERAPEUTICS INC | JSPRW | 399,466 | $7.5M | 4.02% |
| 10 | REVOLUTION MEDICINES INC | RVMDW | 163,500 | $7.4M | 3.97% |
| 11 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 227,700 | $7.3M | 3.91% |
| 12 | TYRA BIOSCIENCES INC | TYRA | 270,075 | $6.3M | 3.40% |
| 13 | ELIEM THERAPEUTICS INC | CLYM | 1,229,292 | $6.3M | 3.35% |
| 14 | GERON CORP | GERN | 1,331,053 | $6.0M | 3.23% |
| 15 | ENLIVEN THERAPEUTICS INC | ELVN | 234,856 | $6.0M | 3.21% |
| 16 | KURA ONCOLOGY INC | KURA | 294,081 | $5.7M | 3.08% |
| 17 | APPLIED THERAPEUTICS INC | 03828A101 | 618,332 | $5.3M | 2.81% |
| 18 | EDGEWISE THERAPEUTICS INC | EWTX | 187,695 | $5.0M | 2.68% |
| 19 | CENTESSA PHARMACEUTICALS | CNTA | 309,614 | $5.0M | 2.65% |
| 20 | JANUX THERAPEUTICS INC | JANX | 108,811 | $4.9M | 2.65% |
| 21 | DISC MEDICINE INC | IRON | 100,000 | $4.9M | 2.63% |
| 22 | PERSPECTIVE THERAPEUTICS INC | CATX | 341,739 | $4.6M | 2.44% |
| 23 | MIND MEDICINE MINDMED INC | 60255C885 | 788,508 | $4.5M | 2.40% |
| 24 | ALUMIS INC | ALMS | 418,416 | $4.5M | 2.39% |
| 25 | RELAY THERAPEUTICS INC | RLAY | 626,058 | $4.4M | 2.37% |
| 26 | TREVI THERAPEUTICS INC | TRVI | 1,322,800 | $4.4M | 2.37% |
| 27 | PRAXIS PRECISION MEDICINES I | PRAX | 73,185 | $4.2M | 2.25% |
| 28 | CONTEXT THERAPEUTICS INC | CNTX | 1,757,524 | $3.4M | 1.84% |
| 29 | PROMIS NEUROSCIENCES INC | PMN | 1,592,605 | $2.0M | 1.07% |